WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report) saw a significant increase in short interest in May. As of May 15th, there was short interest totaling 5,563 shares, an increase of 102.7% from the April 30th total of 2,744 shares. Based on an average daily volume of 950 shares, the days-to-cover ratio is presently 5.9 days. Currently, 3.7% of the company’s stock are sold short.
WisdomTree BioRevolution Fund Price Performance
Shares of WDNA stock opened at $18.33 on Monday. WisdomTree BioRevolution Fund has a 1-year low of $12.28 and a 1-year high of $18.88. The stock’s 50-day moving average is $17.70 and its 200 day moving average is $17.62. The company has a market cap of $2.75 million, a P/E ratio of 17.03 and a beta of 1.01.
Institutional Investors Weigh In On WisdomTree BioRevolution Fund
An institutional investor recently raised its position in WisdomTree BioRevolution Fund stock. Jane Street Group LLC grew its holdings in WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 45.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 16,864 shares of the company’s stock after acquiring an additional 5,306 shares during the quarter. Jane Street Group LLC owned 11.24% of WisdomTree BioRevolution Fund worth $231,000 at the end of the most recent reporting period.
WisdomTree BioRevolution Fund Company Profile
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
Featured Articles
- Five stocks we like better than WisdomTree BioRevolution Fund
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
- 3 Dividend Kings That Earn Their Crown Every Quarter
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.
